Dr. Colin Phipps Diong  Dr. Colin Phipps Diong
 Dr. Colin Phipps Diong

Dr. Colin Phipps Diong


  • Haematology


  • Mandarin
  • English


  • MB BCh BAO (Ireland)
  • MRCP (United Kingdom)
  • FRCPath (United Kingdom)


Dr Colin Phipps Diong is a haematologist at Mount Elizabeth Hospital, Singapore. His subspecialty interest is in lymphoma, leukaemia and myeloma, as well as haematopoietic stem cell transplantation.

Prior to joining Parkway Cancer Centre, Dr Phipps spent 10 years with the department of haematology at Singapore General Hospital. He was appointed as the lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre. He has overseen the management of hundreds of patients with complex blood cancers including resistant lymphomas, and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials. Through investigator-initiated trials, he designed treatment schema incorporating novel targeted agents and immunotherapies into current standard treatment to try to overcome treatment-resistance.

He received his medical degree from the National University of Ireland in 2002 and subsequently completed an internal medicine residency and specialist training in haematology at Singapore General Hospital. He obtained his MRCP (UK) and FRCPath (UK) in 2006 and 2011, respectively. He was awarded the Health Manpower Development Plan (HMDP) fellowship to pursue subspecialty training in lymphoma and bone arrow Ttansplantation at the Fred Hutchinson Cancer Research Centre in Seattle.

Dr Phipps has also been actively involved in undergraduate and postgraduate training of young doctors in Singapore. He currently sits on the residency advisory and exam committees for haematology training in Singapore, medical panel for Bone Marrow Donor Programme, and chairs board F of the ethics committee in SingHealth. He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.


New Treatments For Blood Cancers Offer Better Outcomes

For patients who suffer from particular subtypes of blood cancers like lymphoma, myeloma or leukaemia, a class of drugs known as monoclonal antibodies can offer better outcomes than treatment from chemotherapy alone.

Read More

New Developments in Blood Cancer Treatment (2018)

Over the years, the diagnosis of blood cancers have improved so much that in some cases, a bone marrow examination may not be needed.

Read More

Immunotherapy for Treatment of Blood Cancers

Our immune system comprises organs, cells, and proteins that help us fight infection and disease. It is specifically programmed to recognise things that are not part of our own body, including foreign bacteria, viruses, and fungus.

Read More

Haematopoietic Stem Cell Transplantation (HSCT)

Dr Colin Phipps Diong, Parkway Cancer Centre’s new consultant specialising in lymphoma and blood cancers, and haematopoietic stem cell transplantation, explains haematopoietic stem cell transplantation.

Read More